One effect of BET inhibitors is a reduction in SASP release and BRD4 inhibitors suppress the secretion of SASP mediators, such as IL-1β and CXCL8, from airway epithelial cells from patients with COPD (Khan et al, 2014). Here, IL1B is linked to chronic obstructive pulmonary disease.